Skip to content

Clinical trials

Leukemia-Lymphoma, Adult T-Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia-Lymphoma, Adult T-Cell Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20082
20102
20111
20123
20164
20172
20181
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Terminated3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
MP Biomedicals, LLC3
Kyowa Kirin, Inc.2
Actuate Therapeutics Inc.1
Columbia University1
Daiichi Sankyo Co., Ltd.1
University of Alabama at Birmingham1
University of Miami1
Washington University School of Medicine1
miRagen Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia-Lymphoma, Adult T-Cell20
HTLV-I Infections4
Lymphoma, Non-Hodgkin4
Lymphoma, T-Cell, Cutaneous4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma4
HTLV-II Infections3
Lymphoma, T-Cell, Peripheral3
Paraparesis, Tropical Spastic3
Hodgkin Disease2
Leukemia2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.